Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China · Delayed Price · Currency is CNY 19.95
-2.05 (-9.32%)
Aug 21, 2026, 3:00 PM CST
Aurisco Pharmaceutical Market Cap
Aurisco Pharmaceutical has a market cap or net worth of 8.05 billion as of August 21, 2026. Its market cap has decreased by -19.75% in one year.
Market Cap
8.05B
Enterprise Value
8.10B
Revenue
1.68B
Ranking
n/a
PE Ratio
20.71
Stock Price
19.95
ChartMarket Cap Chart
Since September 21, 2020, Aurisco Pharmaceutical's market cap has increased from 4.83B to 8.05B, an increase of 66.55%. That is a compound annual growth rate of 9.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 8.05B | -20.91% |
| Dec 31, 2025 | 10.18B | 18.61% |
| Dec 31, 2024 | 8.58B | -18.20% |
| Dec 29, 2023 | 10.49B | 4.58% |
| Dec 30, 2022 | 10.03B | 13.58% |
| Dec 31, 2021 | 8.83B | 38.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Hotgen Biotech | 9.16B |
| Shanghai OPM Biosciences | 8.99B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.69B |
| Bio-Thera Solutions | 8.59B |
| Liaoning Chengda Biotechnology | 8.26B |
| Chengdu Easton Biopharmaceuticals | 7.87B |
| Daan Gene | 7.62B |
| Innovita Biological Technology | 7.52B |